查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1573252

慢性疲勞症候群治療藥物市場：依治療類型、年齡層、給藥方法、最終用戶、疾病類型、銷售管道- 2025-2030 年全球預測

Chronic Fatigue Syndrome Treatment Market by Treatment Type (Alternative Treatments, Medications, Therapies), Age Group (Adults, Geriatric, Pediatric), Mode of Administration, End User, Disease Type, Sales Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年慢性疲勞症候群治療藥物市場規模為615.2億美元，預計2024年將達到679.3億美元，複合年成長率為10.87%，2030年將達到1267.3億美元。

慢性疲勞症候群 (CFS) 治療市場的範圍和定義包括了解 CFS 的複雜性和多因素性質，其特徵是持續的、無法解釋的疲勞，干擾日常生活。此外，由於人口老化、意識的提高和診斷技術的改進，對有效治療方法的需求不斷增加，這使得它們變得必要和適用。最終用途包括醫療保健提供者、患者和尋求症狀綜合管理的研究機構，包括藥物治療、行為治療和生活方式改變。關鍵的成長要素包括精準醫療的進步、研發投資的增加以及更強大的醫療基礎設施。這些因素為個人化治療方法（例如基於基因組的療法和綜合醫學框架）提供了機會，以有效滿足個別患者的需求。專注於此類創新的製藥公司和新興企業可以利用未滿足的需求，並有可能重塑市場格局。然而，該市場存在局限性和挑戰，包括缺乏標準化診斷標準、公眾意識低下以及 CFS 研究資金不足，這些都阻礙了成長和創新。此外，慢性疲勞症候群是一種心身疾病，患者症狀的多樣性使得開發治療方法變得困難。創新研究領域包括開發基於生物標記的診斷工具、加強患者教育以及整合多學科知識的共同研究模式。對市場本質的洞察表明，這是一個具有巨大成長潛力的發展中領域，但這需要克服疾病固有的複雜性和恥辱感。公司必須優先考慮以患者為中心的方法並培養與醫療保健提供者和倡導團體的合作夥伴關係來應對這些挑戰。透過專注於整體、全面治療解決方案並利用技術進步，公司不僅可以滿足當前的市場需求，還可以為慢性疲勞症候群治療的未來成長和開拓鋪平道路。

主要市場統計
基準年[2023] 615.2億美元
預測年份 [2024] 679.3億美元
預測年份 [2030] 1267.3億美元
複合年成長率（%） 10.87%

市場動態：快速發展的慢性疲勞症候群治療市場的關鍵市場洞察

供需的動態交互作用正在改變慢性疲勞症候群藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性疲勞症候群的盛行率不斷上升，導致對有效治療解決方案的需求增加
    • 提高對慢性疲勞症候群及其對生活品質影響的認知有助於市場成長
    • 慢性疲勞症候群新治療方法研發進展
    • 醫療保健支出的增加和政府的支持政策推動了慢性疲勞症候群藥物市場的投資
  • 市場限制因素
    • 治療費用上漲且缺乏專門針對慢性疲勞症候群的保險
    • 標準治療很困難，因為症狀的嚴重程度和外觀各不相同。
  • 市場機會
    • 開發營養食品和飲食療法以支持慢性疲勞症候群的恢復
    • 促進慢性疲勞症候群患者的認知行為治療和心理健康支持
    • 更重視大眾意識宣傳活動，教育大眾了解慢性疲勞症候群的現實與管理
  • 市場挑戰
    • 為影響治療開發和可用性的慢性疲勞症候群研究爭取資金的挑戰
    • 慢性疲勞症候群藥物缺乏標準化臨床指引導致患者照護不一致。

波特五力：駕馭慢性疲勞症候群藥物市場的策略工具

波特五力是了解慢性疲勞症候群治療藥物市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解慢性疲勞症候群治療藥物市場的外部影響

外部宏觀環境因素在塑造慢性疲勞症候群治療藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解慢性疲勞症候群治療藥物市場的競爭狀況

對慢性疲勞症候群治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 慢性疲勞症候群治療藥物市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估慢性疲勞症候群治療藥物市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，為慢性疲勞症候群治療藥物市場的成功指明道路

對慢性疲勞症候群治療藥物市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性疲勞症候群的盛行率不斷增加，增加了對有效治療方法的需求。
      • 提高對該疾病及其對生活品質影響的認知有助於市場成長
      • 慢性疲勞症候群醫學研究進展及新治療方法研發
      • 醫療成本上漲和政府支持政策促進醫療投資推動慢性疲勞症候群治療藥物市場
    • 抑制因素
      • 針對慢性疲勞症候群的高治療費用和低保險覆蓋範圍
      • 症狀嚴重程度和表現的差異使得標準化治療變得困難
    • 機會
      • 開發營養食品和飲食計劃以幫助慢性疲勞症候群的恢復
      • 促進慢性疲勞症候群患者的認知行為治療和心理健康支持干預
      • 專注於宣傳宣傳活動，以提高人們對慢性疲勞症候群的現實和管理的認知
    • 任務
      • 確保慢性疲勞症候群研究經費的挑戰影響治療方法的開發和可用性
      • 慢性疲勞症候群藥物缺乏標準化臨床指引導致患者照護不一致
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依治療類型分類的慢性疲勞症候群治療藥物市場

  • 替代治療
    • 針刺
    • 草藥療法
    • 同類療法
  • 藥品
    • 抗憂鬱症
    • 抗病毒藥物
    • 皮質類固醇
    • 免疫調節劑
    • 促智藥
  • 治療方法
    • 認知行為療法
    • 分級運動療法
    • 營養療法

第7章慢性疲勞症候群治療藥物市場：依年齡層

  • 成人
  • 老年病
  • 小兒科

第8章依管理方式分類的慢性疲勞症候群治療藥物市場

  • 可注射的
  • 口服
  • 話題

第9章慢性疲勞症候群治療藥物市場：依最終使用者分類

  • 診所
  • 家庭護理設置
  • 醫院

第10章慢性疲勞症候群治療藥物市場：依疾病類型

  • 原發性慢性疲勞症候群
  • 次發性CFS

第11章慢性疲勞症候群治療藥物市場：依銷售管道

  • 藥局和藥房
  • 網路藥房
  • 處方箋藥房

第12章北美和南美慢性疲勞症候群治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區慢性疲勞症候群治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲慢性疲勞症候群治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C025C

The Chronic Fatigue Syndrome Treatment Market was valued at USD 61.52 billion in 2023, expected to reach USD 67.93 billion in 2024, and is projected to grow at a CAGR of 10.87%, to USD 126.73 billion by 2030.

The scope and definition of the chronic fatigue syndrome (CFS) treatment market involve understanding the complex and multifactorial nature of CFS, characterized by persistent and unexplained fatigue interfering with daily functioning. Necessity and application arise from the increasing demand for effective treatment solutions, driven by an aging population, growing awareness, and improved diagnostic techniques. End-use scope spans healthcare providers, patients, and research institutions seeking comprehensive management of symptoms, which may include medications, behavioral therapies, and lifestyle modifications. Key growth factors include advancements in precision medicine, growing investment in research and development, and enhanced healthcare infrastructure. These factors present opportunities in personalized treatment approaches, such as genomic-based therapies and integrative medicine frameworks to address individual patient needs more effectively. Pharmaceutical companies and startups focusing on such innovations can capitalize on unmet demand, potentially reshaping the market landscape. However, the market faces limitations and challenges, including the lack of standardized diagnostic criteria, low public awareness, and insufficient funding for CFS research, which impede growth and innovation. Additional challenges include the stigmatization of CFS as a psychosomatic illness and the high heterogeneity in patient symptoms, complicating treatment development. Innovative areas for exploration include the development of biomarker-based diagnostic tools, enhanced patient education initiatives, and collaborative research models integrating multi-disciplinary insights. Insights into the nature of the market reveal an evolving space with significant potential for growth, though it requires overcoming the inherent complexities and stigmas associated with the condition. Companies should prioritize patient-centric approaches and foster collaborations with healthcare providers and advocacy groups to navigate these challenges. By focusing on holistic, integrative treatment solutions and leveraging technological advancements, businesses can not only meet current market demands but also pave the way for future growth and development in CFS treatment.

KEY MARKET STATISTICS
Base Year [2023] USD 61.52 billion
Estimated Year [2024] USD 67.93 billion
Forecast Year [2030] USD 126.73 billion
CAGR (%) 10.87%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chronic Fatigue Syndrome Treatment Market

The Chronic Fatigue Syndrome Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic fatigue syndrome leading to higher demand for effective treatment solutions
    • Rising awareness about the condition and its impact on quality of life contributing to market growth
    • Advancements in medical research and development of new treatment modalities for chronic fatigue syndrome
    • Growing healthcare expenditure and supportive government policies boosting investments in chronic fatigue syndrome treatment market
  • Market Restraints
    • High cost of treatment and lack of insurance coverage specific to chronic fatigue syndrome
    • Variability in severity and manifestation of symptoms making standardized treatment difficult
  • Market Opportunities
    • Development of targeted nutritional supplements and dietary plans to assist chronic fatigue syndrome recovery
    • Promotion of cognitive behavioral therapy and mental health support interventions for chronic fatigue syndrome patients
    • Greater emphasis on public awareness campaigns to educate about the reality and management of chronic fatigue syndrome
  • Market Challenges
    • Challenges in securing funding for chronic fatigue syndrome research affecting treatment development and availability
    • Lack of standardized clinical guidelines for chronic fatigue syndrome treatment causing inconsistencies in patient care

Porter's Five Forces: A Strategic Tool for Navigating the Chronic Fatigue Syndrome Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chronic Fatigue Syndrome Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chronic Fatigue Syndrome Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chronic Fatigue Syndrome Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chronic Fatigue Syndrome Treatment Market

A detailed market share analysis in the Chronic Fatigue Syndrome Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chronic Fatigue Syndrome Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chronic Fatigue Syndrome Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chronic Fatigue Syndrome Treatment Market

A strategic analysis of the Chronic Fatigue Syndrome Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Fatigue Syndrome Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Allergan plc, Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Roche Holding AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Vertex Pharmaceuticals Incorporated.

Market Segmentation & Coverage

This research report categorizes the Chronic Fatigue Syndrome Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Alternative Treatments, Medications, and Therapies. The Alternative Treatments is further studied across Acupuncture, Herbal Remedies, and Homeopathy. The Medications is further studied across Antidepressants, Antiviral Agents, Corticosteroids, Immunomodulatory Agents, and Nootropic Agents. The Therapies is further studied across Cognitive Behavioral Therapy, Graded Exercise Therapy, and Nutritional Therapy.
  • Based on Age Group, market is studied across Adults, Geriatric, and Pediatric.
  • Based on Mode of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on End User, market is studied across Clinics, Homecare Settings, and Hospitals.
  • Based on Disease Type, market is studied across Primary CFS and Secondary CFS.
  • Based on Sales Channel, market is studied across Drug Stores And Retail Pharmacies, Online Pharmacies, and Prescription-Based Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic fatigue syndrome leading to higher demand for effective treatment solutions
      • 5.1.1.2. Rising awareness about the condition and its impact on quality of life contributing to market growth
      • 5.1.1.3. Advancements in medical research and development of new treatment modalities for chronic fatigue syndrome
      • 5.1.1.4. Growing healthcare expenditure and supportive government policies boosting investments in chronic fatigue syndrome treatment market
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment and lack of insurance coverage specific to chronic fatigue syndrome
      • 5.1.2.2. Variability in severity and manifestation of symptoms making standardized treatment difficult
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of targeted nutritional supplements and dietary plans to assist chronic fatigue syndrome recovery
      • 5.1.3.2. Promotion of cognitive behavioral therapy and mental health support interventions for chronic fatigue syndrome patients
      • 5.1.3.3. Greater emphasis on public awareness campaigns to educate about the reality and management of chronic fatigue syndrome
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges in securing funding for chronic fatigue syndrome research affecting treatment development and availability
      • 5.1.4.2. Lack of standardized clinical guidelines for chronic fatigue syndrome treatment causing inconsistencies in patient care
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chronic Fatigue Syndrome Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Alternative Treatments
    • 6.2.1. Acupuncture
    • 6.2.2. Herbal Remedies
    • 6.2.3. Homeopathy
  • 6.3. Medications
    • 6.3.1. Antidepressants
    • 6.3.2. Antiviral Agents
    • 6.3.3. Corticosteroids
    • 6.3.4. Immunomodulatory Agents
    • 6.3.5. Nootropic Agents
  • 6.4. Therapies
    • 6.4.1. Cognitive Behavioral Therapy
    • 6.4.2. Graded Exercise Therapy
    • 6.4.3. Nutritional Therapy

7. Chronic Fatigue Syndrome Treatment Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Geriatric
  • 7.4. Pediatric

8. Chronic Fatigue Syndrome Treatment Market, by Mode of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Chronic Fatigue Syndrome Treatment Market, by End User

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Homecare Settings
  • 9.4. Hospitals

10. Chronic Fatigue Syndrome Treatment Market, by Disease Type

  • 10.1. Introduction
  • 10.2. Primary CFS
  • 10.3. Secondary CFS

11. Chronic Fatigue Syndrome Treatment Market, by Sales Channel

  • 11.1. Introduction
  • 11.2. Drug Stores And Retail Pharmacies
  • 11.3. Online Pharmacies
  • 11.4. Prescription-Based Pharmacies

12. Americas Chronic Fatigue Syndrome Treatment Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Chronic Fatigue Syndrome Treatment Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Chronic Fatigue Syndrome Treatment Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

LIST OF FIGURES

  • FIGURE 1. CHRONIC FATIGUE SYNDROME TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. CHRONIC FATIGUE SYNDROME TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CHRONIC FATIGUE SYNDROME TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHRONIC FATIGUE SYNDROME TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHRONIC FATIGUE SYNDROME TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HERBAL REMEDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOMEOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY IMMUNOMODULATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NOOTROPIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY GRADED EXERCISE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY NUTRITIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRIMARY CFS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SECONDARY CFS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY PRESCRIPTION-BASED PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY ALTERNATIVE TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS CHRONIC FATIGUE SYNDROME TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. NET